TABLE 1

Mean (±SD) age, BMI, HbA1c, years of OHA or insulin therapy, and fasting C-peptide concentrations, as well as gender distribution, in the nondiabetic subjects and patients with type 2 diabetes treated with OHA or insulin

NondiabeticType 2 diabetic patients
OHA RxInsulin Rx
Age (years)50 ± 656 ± 657 ± 6
Female/male8/74/33/3
BMI (kg/m2)30.2 ± 1.032.4 ± 2.734.0 ± 2.7
HbAlc (%)5.6 ± 0.48.6 ± 1.17.5 ± 0.7
Years of OHA or insulin Rx10 ± 55 ± 3
Fasting C-peptide (ng/ml)*2.3 ± 1.13.1 ± 1.71.1 ± 0.4
  • *

    * Multiply ng/ml by 0.331 to convert to nmol/l.

  • P = 0.0051 versus nondiabetic and 0.0172 versus type 2 diabetic OHA Rx.